Chemoinformaics analysis of ABIETIC-ACID-METHYL-ESTER
| Molecular Weight | 472.71 | nRot | 1 |
| Heavy Atom Molecular Weight | 424.326 | nRig | 27 |
| Exact Molecular Weight | 472.355 | nRing | 5 |
| Solubility: LogS | -3.74 | nHRing | 0 |
| Solubility: LogP | 5.417 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 85.3141 |
| nHD | 3 | BPOL | 49.0219 |
| QED | 0.397 |
| Synth | 4.883 |
| Natural Product Likeliness | 3.241 |
| NR-PPAR-gamma | 0.97 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.026 |
| CACO-2 | -5.313 |
| MDCK | 0.0000157 |
| BBB | 0.799 |
| PPB | 0.941349 |
| VDSS | 0.791 |
| FU | 0.0453371 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.267 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.918 |
| CYP2c9-inh | 0.119 |
| CYP2c9-sub | 0.909 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.408 |
| CYP3a4-inh | 0.106 |
| CYP3a4-sub | 0.159 |
| CL | 4.623 |
| T12 | 0.022 |
| hERG | 0.002 |
| Ames | 0.021 |
| ROA | 0.228 |
| SkinSen | 0.012 |
| Carcinogencity | 0.044 |
| EI | 0.04 |
| Respiratory | 0.956 |
| NR-Aromatase | 0.82 |
| Antiviral | No |
| Prediction | 0.694071 |